Prolight’s COO to BioStock: “The pilot line sets the stage for scalability”

Prolight Diagnostics recently completed a business review of the pilot manufacturing line at its partner, FlexMedical Solutions. The production line will supply cartridges for the upcoming clinical performance study of the Psyros POC platform and facilitate a seamless transition to full-scale commercial production. Prolight’s COO, Karl Bullen, shared insights into the progress and next steps.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/10/prolights-coo-the-pilot-line-sets-the-stage-for-scalability/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se